Medindia

X

ETHICON Launches the Latest Innovation in Hernia Repair Platform; PROCEED(TM) Ventral Patch (PVP(TM) Device)

Wednesday, December 17, 2008 General News J E 4
Advertisement
New System Capitalizes on Innovative Materials and Technology



SOMERVILLE, N.J., Dec. 16 /PRNewswire/ -- ETHICON, INC, a global medical device company, today announced the launch of the PROCEED Ventral Patch (PVP Device), the latest addition to its family of hernia products. PVP Device is the first and only umbilical hernia repair device featuring lighter-weight mesh and exclusive, absorbable deployment technology. It is indicated for use in umbilical, epigastric, small ventral and trocar site hernias.



Hernias are extremely common. Umbilical hernias occur near the belly button or navel, which has a natural weakness from the blood vessels of the umbilical cord. These hernias may occur in infants at or just after birth, and may resolve at 3 or 4 years of age. However, the area of weakness can persist throughout life and can occur in men, women, and children at any time. In adults, umbilical hernias will not resolve and may progressively worsen over time. They are sometimes caused by abdominal pressure due to being overweight, excessive coughing, or pregnancy.



The PROCEED Ventral Patch is a sterile, self-expanding, partially absorbable, flexible mesh device that utilizes the proven design of PROCEED Surgical Mesh. The unique product design offers surgeons secure and stable deployment,(1) strength without ePTFE (expanded polytetrafluoroethylene),(2) and a macroporous / partially absorbable construction.(3) The PVP Device is available in small (4.3 cm) and medium (6.4 cm) sizes.



Dr. Carl Doerhoff, the first surgeon to implant the PVP Device in a human patient in the US, stated, "I'm very excited about the new technology advancements present in the PVP Device. Knowing that the product is flexible and partially absorbable for a greater likelihood of long-term patient comfort is an added benefit."



The PROCEED Ventral Patch is made by ETHICON, INC., a Johnson & Johnson company. ETHICON continues Johnson & Johnson's 100-year commitment to wound care today with innovative products for general surgery, wound management, women's health and urology, and wound closure. For more information about ETHICON visit www.ethicon.com.



(1) Data on file. ETHICON, INC.

(2) Welty G, Klinge U, Klosterhalfen B, Kasperk R, Schumpelick V. Functional impairment and complaints following incisional hernia repair with different polypropylene meshes. Hernia. 2001;5(3):142-147.

(3) Harrell AG, Novitsky YW, Cristiano JA, et al. Prospective histologic evaluation of intra-abdominal prosthetics four months after implantation in a rabbit model. Surg Endosc. 2007;21:1170-1174.



Contact: Michelle Bauman (908) 218-2463 ETHICON, Inc. mbauman@its.jnj.com

SOURCE ETHICON, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Independence Blue Cross Extends Funding to Enhance...
S
Colorado Among First States in Nation to Share Hea...